Skip directly to search Skip directly to A to Z list Skip directly to site content

Uranium Toxicity
Cover Page

Course: WB 1524
CE Original Date: May 6, 2009
CE Renewal Date: May 6, 2012
CE Expiration Date: May 6, 2014
Download Printer-Friendly version [PDF - 439 KB]

Next Section

Key Concepts

  • Everyone is exposed to uranium in food, air, and water as part of the natural environment. Most exposures do not warrant monitoring or treatment.
  • Populations most heavily exposed to uranium are those employed in mining and milling operations, or in uranium enrichment and processing activities.
  • Natural and depleted uranium are primarily chemical toxicants, with radiation playing a minor role or no role at all.
  • Outcomes that may occur with uranium overexposure, based on both observed human effects and animal studies, include non-malignant respiratory disease (fibrosis, emphysema) and nephrotoxicity.
  • Nephrotoxicity should reverse as overexposure ceases.
  • Alpha radiation (such as that from uranium) is classified as a human carcinogen. However, human studies have not found elevated rates of cancer from uranium exposure, and high-dose animal studies have not found cancer following inhalation, oral, or dermal exposure to uranium.

About This and Other Case Studies in Environmental Medicine

This educational case study document is one in a series of self-instructional courses designed to increase the primary care provider's knowledge of hazardous substances in the environment and to promote the adoption of medical practices that aid in the evaluation and care of potentially exposed patients. The complete series of Case Studies in Environmental Medicine is located on the ATSDR Web site at In addition, the downloadable PDF [439 KB] version of this educational series and other environmental medicine materials provides content in an electronic, printable format, especially for those who may lack adequate Internet service.

How to Apply for and Receive Continuing Education Credit

See Training and Continuing Education Online for more information about continuing medical education credits, continuing nursing education credits, and other continuing education units.


We gratefully acknowledge the work that the physician writers, editors, and reviewers have provided to produce this educational resource. Listed below are those who have contributed to development of this version of the Case Study in Environmental Medicine.

Please Note: Each content expert for this case study has indicated that there is no conflict of interest to disclose that would bias the case study content.

ATSDR Authors: Kim Gehle MD, MPH

ATSDR Planners: Charlton Coles, PhD; John Doyle, MPA; Bruce Fowler, PhD; Kimberly Gehle, MD; Sharon L. Hall, PhD; Michael Hatcher, DrPH; Kimberly Jenkins, BA; Ronald T. Jolly; Barbara M. Riley, RN; Delene Roberts, MSA; Oscar Tarrago, MD, MPH, CHES; Brian Tencza, MS.

Contributors: Sam Keith, SB, MS; Association of Occupational and Environmental Clinics (AOEC) contractors: Denece Kesler, MD, Madu Arora, MD, Kerrie Seger, MD, Philip Wagner, MD, Monica Pourrat, MD, Joanne Keefe, RN, Joyce Van Dellen, CNP, Melanie Valdez, RN, Jean Jones, NP, Patti Austin, NP, Tom White, PA, Herman J. Gibb, PhD, Joseph Burnell, PhD, Ed Maibach, PhD, M. Haider, PhD.

Peer Reviewers: Sam Keith, SB, MS, ATSDR; Dr. Gayle Debord, PhD, NIOSH; and Mary E. Mortensen, MD, NCEH/DLS.

Disclaimer and Disclosure


The state of knowledge regarding the treatment of patients potentially exposed to hazardous substances in the environment is constantly evolving and is often uncertain. In developing its educational products ATSDR has made a diligent effort to ensure the accuracy and the currency of the presented information. ATSDR, however, makes no claim that the environmental medicine and health education resources discussed in these products comprehensively address all possible situations related to various substances. The products are intended for educational use to build the knowledge of physicians and other health professionals in assessing the conditions and managing the treatment of patients potentially exposed to hazardous substances. The products are not a substitute for a health-care provider’s professional judgment. Please interpret the environmental medicine and the health education resources in light of specific information regarding the patient and in conjunction with other medical authorities. Use of trade names in ATSDR products is for identification purposes only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry or the U.S. Department of Health and Human Services.


In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use. CDC, our planners, and the presenters for this seminar do not have financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. This presentation does not involve the unlabeled use of a product or product under investigational use. There was no commercial support for this activity.

U.S. Department of Health and Human Services
Agency for Toxic Substances and Disease Registry
Division of Toxicology and Environmental Medicine
Environmental Medicine and Educational Services Branch

Next Section The U.S. Government's Official Web PortalDepartment of Health and Human Services
Agency for Toxic Substances and Disease Registry, 4770 Buford Hwy NE, Atlanta, GA 30341
Contact CDC: 800-232-4636 / TTY: 888-232-6348

A-Z Index

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #